Jiangsu Nhwa Pharmaceutical Co Ltd (SHE:002262) — Stock Price

CN¥22.37 CNY
▲ 2.43% today

Jiangsu Nhwa Pharmaceutical Co Ltd (SHE:002262) is currently trading at CN¥22.37 CNY, up 2.43% today. Over the past 52 weeks, shares have ranged between CN¥18.23 and CN¥28.92. This page tracks Jiangsu Nhwa Pharmaceutical Co Ltd's live share price on the SHE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of Jiangsu Nhwa Pharmaceutical Co Ltd.

Jiangsu Nhwa Pharmaceutical Co Ltd (002262) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Jiangsu Nhwa Pharmaceutical Co Ltd's daily closing share price and trading volume on the SHE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Jiangsu Nhwa Pharmaceutical Co Ltd Income Statement — Revenue, Profit & Earnings by Year

Jiangsu Nhwa Pharmaceutical Co Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue CN¥5.91 Billion CN¥5.70 Billion CN¥5.04 Billion CN¥4.30 Billion CN¥3.94 Billion
Cost of Revenue CN¥1.65 Billion CN¥1.55 Billion CN¥1.40 Billion CN¥1.04 Billion CN¥932.68 Million
Gross Profit CN¥4.26 Billion CN¥4.15 Billion CN¥3.64 Billion CN¥3.26 Billion CN¥3.00 Billion
Research & Development CN¥685.54 Million CN¥611.54 Million CN¥549.32 Million CN¥454.25 Million CN¥351.73 Million
SG&A CN¥1.72 Billion CN¥258.76 Million CN¥207.12 Million CN¥192.57 Million CN¥148.41 Million
Total Operating Expenses CN¥4.75 Billion CN¥2.82 Billion CN¥2.46 Billion CN¥2.26 Billion CN¥2.08 Billion
Operating Income CN¥1.16 Billion CN¥1.34 Billion CN¥1.18 Billion CN¥1.00 Billion CN¥925.87 Million
EBITDA — CN¥1.36 Billion CN¥1.20 Billion CN¥1.02 Billion CN¥959.57 Million
EBIT — CN¥1.21 Billion CN¥1.07 Billion CN¥901.63 Million CN¥847.28 Million
Interest Expense CN¥2.44 Million CN¥5.30 Million CN¥4.96 Million CN¥5.65 Million CN¥6.10 Million
Income Before Tax CN¥1.17 Billion CN¥1.30 Billion CN¥1.17 Billion CN¥989.91 Million CN¥915.78 Million
Income Tax Expense — CN¥155.90 Million CN¥134.40 Million CN¥109.82 Million CN¥117.75 Million
Net Income CN¥1.06 Billion CN¥1.14 Billion CN¥1.04 Billion CN¥900.71 Million CN¥797.78 Million

Jiangsu Nhwa Pharmaceutical Co Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Jiangsu Nhwa Pharmaceutical Co Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets CN¥9.22 Billion CN¥8.44 Billion CN¥7.33 Billion CN¥6.48 Billion CN¥5.70 Billion
Total Current Assets CN¥6.46 Billion CN¥6.06 Billion CN¥5.25 Billion CN¥4.65 Billion CN¥4.04 Billion
Cash & Equivalents — — — — —
Short-term Investments CN¥2.57 Billion CN¥2.37 Billion CN¥1.33 Billion CN¥1.45 Billion CN¥1.06 Billion
Net Receivables CN¥1.47 Billion CN¥1.52 Billion CN¥1.08 Billion CN¥873.86 Million CN¥737.76 Million
Inventory CN¥756.78 Million CN¥661.39 Million CN¥628.64 Million CN¥716.34 Million CN¥604.33 Million
Property, Plant & Equipment — — — CN¥1.30 Billion CN¥1.16 Billion
Goodwill — — — — —
Total Liabilities CN¥1.20 Billion CN¥1.17 Billion CN¥918.09 Million CN¥897.43 Million CN¥793.45 Million
Total Current Liabilities CN¥1.09 Billion CN¥1.07 Billion CN¥814.03 Million CN¥793.94 Million CN¥681.96 Million
Long-term Debt CN¥230.00K CN¥230.00K CN¥230.00K CN¥230.00K CN¥230.00K
Net Debt — CN¥-1.37 Billion CN¥-2.07 Billion CN¥-1.46 Billion CN¥-1.52 Billion
Total Stockholder Equity CN¥8.06 Billion CN¥7.30 Billion CN¥6.43 Billion CN¥5.62 Billion CN¥4.92 Billion
Retained Earnings CN¥6.32 Billion CN¥5.63 Billion CN¥4.81 Billion CN¥3.98 Billion CN¥3.37 Billion

Jiangsu Nhwa Pharmaceutical Co Ltd Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Jiangsu Nhwa Pharmaceutical Co Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow CN¥1.08 Billion CN¥916.13 Million CN¥1.01 Billion CN¥861.02 Million CN¥701.12 Million
Capital Expenditures CN¥437.41 Million CN¥450.06 Million CN¥373.99 Million CN¥327.75 Million CN¥206.11 Million
Free Cash Flow CN¥640.98 Million CN¥466.07 Million CN¥634.31 Million CN¥533.27 Million CN¥495.01 Million
Investing Cash Flow — CN¥-1.41 Billion CN¥-293.39 Million CN¥-688.90 Million CN¥-392.52 Million
Financing Cash Flow — CN¥-300.97 Million CN¥-210.17 Million CN¥-240.78 Million CN¥-127.43 Million
Dividends Paid CN¥-366.21 Million CN¥323.77 Million CN¥201.52 Million CN¥201.52 Million CN¥100.76 Million
Stock-Based Compensation — — — — CN¥2.49 Million
Depreciation CN¥197.56 Million CN¥182.01 Million CN¥164.08 Million CN¥148.66 Million CN¥135.06 Million
Change in Cash CN¥129.32 Million CN¥-796.15 Million CN¥505.15 Million CN¥-67.75 Million CN¥180.02 Million

Jiangsu Nhwa Pharmaceutical Co Ltd Earnings History — EPS Actual vs. Analyst Estimates

Track Jiangsu Nhwa Pharmaceutical Co Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Apr 17, 2026 -0.04 0.12 -133.33%
Dec 31, 2025 -0.04 0.12 -133.33%
Oct 24, 2025 0.40 0.44 -9.09%
Jul 29, 2025 0.39 0.41 -4.88%
Apr 18, 2025 0.30 0.31 -3.23%
Mar 28, 2025 0.12 0.17 -29.41%
Oct 25, 2024 0.38 0.40 -5.00%
Jul 30, 2024 0.36 0.37 -2.70%